Copperleaf Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,137
Closed -$202K 72
2022
Q2
$202K Buy
+1,137
New +$203K 0.2% 61
2020
Q3
Sell
-1,600
Closed -$225K 54
2020
Q2
$225K Hold
1,600
0.23% 47
2020
Q1
$210K Sell
1,600
-473
-23% -$67.1K 0.25% 40
2019
Q4
$302K Buy
+2,073
New +$281K 0.31% 41

Other funds holding JNJ

Copperleaf Capital's JNJ Position: Q3 2022 in Review

Copperleaf Capital sold out of Johnson & Johnson (JNJ) in Q3 2022, closing a stake of 1,137 shares — an estimated $202K sold.

Copperleaf Capital first reported a position in JNJ in Q4 2019 and held it in 4 quarters. The position peaked at $302K in Q4 2019. 3,623 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.

  • Copperleaf Capital reported no remaining Johnson & Johnson position as of Q3 2022 after selling out during the quarter.
  • Copperleaf Capital sold 1,137 Johnson & Johnson shares in Q3 2022, an estimated $202K.
  • Copperleaf Capital first reported a position in Johnson & Johnson in Q4 2019 and held it in 4 quarters.
  • Copperleaf Capital's Johnson & Johnson position peaked at $302K in Q4 2019.
  • 3,623 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.

Based on Copperleaf Capital's 13F filing for Q3 2022, filed 14 Nov 2022.